Given the hypothesized dysfunction of the NMDA receptor in schizophrenia, efforts to enhance glycinergic neurotransmission through GlyT1 inhibition gained traction as a therapeutic strategy
The lack of comprehensive human trials means potential dangers and interactions with other medications remain uncertain
Both conditions (treatment and control) were analyzed in 3 biological triplicates for each cell line
Clinical trials show substantial weight loss, especially when combined with semaglutide
Vasconcelos SMM, Cavalcante RA, Aguiar LMV, Sousa FCF, Fonteles MMF, Viana GSB (2004) Effects of chronic ethanol treatment on monoamine levels in rat hippocampus and striatum
Dysports dosing differs from other neuromodulator injections, such as Botox